ENTXW Entera Bio Ltd.

Fundamentals / CIK 0001638097 / USD
Other share classes on CIK 0001638097: ENTX

Entera Bio Ltd. reported $0 in revenue and a net loss of $29.43M for the trailing twelve months ended September 30, 2026 (down 76.8% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ENTXW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.94M$972K$0-$12.27MFY 2016 Net Income: -$1.20M2016FY 2017 Net Income: -$11.20M2017FY 2018 Revenue: $500KFY 2018 Net Income: -$10.30M2018FY 2019 Revenue: $236KFY 2019 Net Income: -$10.79M2019FY 2020 Revenue: $365KFY 2020 Net Income: -$11.22M2020FY 2021 Revenue: $571KFY 2021 Net Income: -$12.19M2021FY 2022 Revenue: $134KFY 2022 Net Income: -$13.07M2022FY 2023 Revenue: $0FY 2023 Net Income: -$8.89M2023FY 2024 Revenue: $181KFY 2024 Net Income: -$9.54M2024FY 2025 Revenue: $42KFY 2025 Net Income: -$11.44M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $42K $181K $0 $134K $571K $365K $236K $500K -- --
Cost of Revenue $42K $172K $0 $101K $373K $300K $210K -- -- --
Gross Profit $0 $9.0K $0 $33K $198K $65K $26K -- -- --
Research & Development $6.00M $4.50M $4.51M $5.85M $6.77M $6.38M $7.20M $8.52M $2.77M $2.65M
Selling, General & Admin $398K $340K -- -- -- -- -- -- -- --
Total Operating Expenses $11.53M $9.59M $8.89M $13.05M $12.41M $11.23M -- -- -- --
Operating Income -$11.53M -$9.59M -$8.89M -$13.02M -$12.22M -$11.17M -$11.45M -$10.86M -$11.34M -$5.37M
EBITDA -$11.50M -$9.54M -$8.84M -$12.95M -$12.16M -$11.11M -$11.22M -$10.81M -$11.30M -$5.33M
Income Before Tax -$11.44M -$9.53M -$8.86M -$12.93M -$12.25M -$11.20M -$10.79M -$10.30M -- --
Income Tax Expense $0 $14K $29K $137K -$59K $20K -- -- -- --
Net Income -$11.44M -$9.54M -$8.89M -$13.07M -$12.19M -$11.22M -$10.79M -$10.30M -$11.20M -$1.20M
Basic EPS $0.25 $0.25 $0.31 $0.45 $0.47 $0.67 $0.89 $1.30 $2.49 $0.27
Diluted EPS $0.25 $0.25 $0.31 $0.45 $0.47 $0.67 $0.89 $1.31 $2.49 $0.78
Basic Shares Outstanding 46.2M 37.7M 29.0M 28.8M 26.1M 18.4M 12.1M 8.0M 4.5M 4.5M
Diluted Shares Outstanding 46.2M 37.7M 29.0M 28.8M 26.1M 18.4M 12.1M 8.0M 4.5M 6.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $42K $82K
Cost of Revenue $0 $0 $0 $0 $0 $0 $42K $82K
Gross Profit $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $4.92M $3.20M $2.25M $1.72M $1.64M $1.52M $1.12M $1.20M
Selling, General & Admin $157K $124K $128K $54K $118K $103K $123K --
Total Operating Expenses $7.26M $4.56M $3.54M $3.04M $3.26M $2.67M $2.56M $2.34M
Operating Income -$7.26M -$4.56M -$3.54M -$3.04M -$3.26M -$2.67M -$2.56M -$2.34M
EBITDA -$7.26M -$4.55M -$3.53M -$3.04M -$3.25M -$2.66M -$2.56M -$2.33M
Net Income -$15.60M -$7.31M -$3.50M -$3.02M -$3.20M -$2.66M -$2.57M -$2.36M
Basic EPS $0.11 $0.14 $0.07 -- $0.07 $0.06 $0.06 --
Diluted EPS $0.11 $0.14 $0.07 -- $0.07 $0.06 $0.06 --
Basic Shares Outstanding 145.1M 50.5M 47.8M -- 47.1M 46.8M 43.4M --
Diluted Shares Outstanding 145.1M 50.5M 47.8M -- 47.1M 46.8M 43.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.11M $8.66M $11.02M $12.31M $24.89M $8.59M $15.19M $7.51M $11.75M
Cash & Short-Term Investments $7.11M $8.66M $11.02M $12.31M $24.89M $8.59M $15.19M $7.51M $11.75M
Accounts Receivable, Net $0 $126K $0 $246K $183K $255K $278K $725K --
Other Current Assets $107K $186K $238K $294K $254K $261K $97K $90K $159K
Total Current Assets $15.30M $8.97M $11.26M $12.85M $25.33M $9.11M $15.64M $12.47M $12.42M
Property, Plant & Equipment, Net $134K $57K $100K $139K $156K $192K $202K $224K $207K
Intangible Assets -- -- -- -- -- $605K $605K $651K $654K
Total Non-Current Assets $695K $418K $508K $278K $658K $613K $1.07M $875K $861K
Total Assets $15.99M $9.39M $11.77M $13.13M $25.99M $9.72M $16.70M $13.34M $13.28M
Accounts Payable $448K $132K $83K $17K $166K $164K $334K $473K $596K
Deferred Revenue (Current) -- -- -- $0 $15K $158K $267K $225K --
Total Current Liabilities $2.20M $1.18M $1.09M $1.34M $3.16M $1.84M $4.59M $3.16M $2.02M
Long-Term Debt -- -- -- -- -- -- -- -- $3.89M
Other Non-Current Liabilities $393K $0 -- -- -- -- -- -- --
Total Non-Current Liabilities $689K $134K $288K $32K $261K $371K $192K $65K $42.82M
Total Liabilities $2.89M $1.31M $1.38M $1.37M $3.42M $2.21M $4.78M $3.23M $44.84M
Total Debt (incl. Leases) $490K $272K $390K $91K $302K $432K $299K -- $3.89M
Common Stock $1.0K $1.0K $1.0K -- -- -- -- -- --
Retained Earnings -$125.4M -$113.9M -$104.4M -$95.50M -$82.43M -$70.24M -$62.91M -$52.12M -$41.81M
Accumulated Other Comp. Income $41K $41K $41K $41K $41K $41K $11.40M $13.02M $7.36M
Total Stockholders' Equity $13.10M $8.08M $10.39M $11.75M $22.57M $7.51M $13.77M $10.12M -$31.56M
Total Equity $13.10M $8.08M $10.39M $11.75M $22.57M $7.51M $13.77M $10.12M -$31.56M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $265.9M $11.31M $4.14M $7.11M $8.57M $10.86M $12.57M $8.66M
Cash & Short-Term Investments $265.9M $11.31M $4.14M $7.11M $8.57M $10.86M $12.57M $8.66M
Accounts Receivable, Net -- -- -- $0 $0 $0 $126K $126K
Other Current Assets $182K $144K $256K $107K $262K $192K $165K $186K
Total Current Assets $276.5M $18.90M $12.49M $15.30M $17.01M $19.31M $21.22M $8.97M
Property, Plant & Equipment, Net $133K $121K $127K $134K $114K $79K $57K $57K
Total Non-Current Assets $575K $584K $636K $695K $400K $356K $382K $418K
Total Assets $277.0M $19.48M $13.13M $15.99M $17.41M $19.67M $21.60M $9.39M
Accounts Payable $406K $575K $274K $448K $216K $383K $134K $132K
Total Current Liabilities $2.15M $2.10M $1.58M $2.20M $1.57M $1.84M $1.62M $1.18M
Other Non-Current Liabilities -- -- -- $393K -- -- -- $0
Total Non-Current Liabilities $605K $10.11M $866K $689K $602K $567K $598K $134K
Total Liabilities $2.76M $12.21M $2.44M $2.89M $2.17M $2.41M $2.22M $1.31M
Total Debt (incl. Leases) $397K $425K $448K $490K $211K $203K $220K $272K
Common Stock $5.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$151.8M -$136.2M -$128.9M -$125.4M -$122.3M -$119.2M -$116.5M -$113.9M
Accumulated Other Comp. Income $41K $41K $41K $41K $41K $41K $41K $41K
Total Stockholders' Equity $274.3M $7.27M $10.69M $13.10M $15.23M $17.26M $19.38M $8.08M
Total Equity $274.3M $7.27M $10.69M $13.10M $15.23M $17.26M $19.38M $8.08M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.44M -$9.54M -$8.89M -$13.07M -$12.19M -$11.22M -$10.79M -$10.30M -$11.20M -$1.20M
Depreciation & Amortization $30K $46K $56K $64K $53K $63K $238K $54K $43K $35K
Stock-Based Compensation $2.75M $2.56M $1.69M $2.25M $1.86M $901K $1.48M $1.23M $4.88M $1.49M
Change in Receivables $126K -$126K $246K -$63K $72K $23K $447K -$725K -- --
Change in Payables $316K $49K $66K -$149K $2.0K -$170K -$139K -$123K $543K -$298K
Operating Cash Flow -$7.37M -$6.82M -$7.31M -$12.50M -$9.06M -$10.56M -$8.92M -$9.80M -$4.53M -$3.14M
Capital Expenditure -$107K -$3.0K -$17K -$47K -$17K -$53K -$40K -$68K -$51K -$41K
Free Cash Flow -$7.48M -$6.82M -$7.33M -$12.55M -$9.08M -$10.61M -$8.96M -$9.86M -$4.58M -$3.18M
Investing Cash Flow -$107K -$3.0K -$17K -$102K -$17K -$53K $3.95M -$4.07M $1.00M -$1.12M
Common Stock Issued $6.25M $3.96M $5.0K $0 $21.80M $3.19M -- -- $12.09M --
Financing Cash Flow $13.71M $4.48M $6.04M $13K $25.38M $4.05M $12.65M $9.62M $11.11M $7.22M
Net Change in Cash $6.20M -$2.35M -$1.29M -$12.59M $16.30M -$6.56M $7.68M -$4.24M $7.58M $2.96M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$15.60M -$7.31M -$3.50M -$3.02M -$3.20M -$2.66M -$2.57M -$2.36M
Depreciation & Amortization $9.0K $9.0K $7.0K $7.0K $8.0K $7.0K $8.0K $11K
Stock-Based Compensation $1.82M $624K $672K $710K $927K $509K $604K $566K
Change in Receivables -- -- -- -- -- -- -- $7.0K
Change in Payables -$169K $301K -$174K $232K -$167K $249K $2.0K -$52K
Operating Cash Flow -$7.40M -$3.46M -$3.09M -$1.83M -$2.50M -$1.63M -$1.40M -$1.47M
Capital Expenditure -$21K -$3.0K $0 -$27K -$43K -$29K -$8.0K -$3.0K
Free Cash Flow -$7.42M -$3.47M -$3.09M -$1.86M -$2.54M -$1.66M -$1.41M -$1.47M
Investing Cash Flow -$21K -$3.0K $0 -$27K -$43K -$29K -$8.0K -$3.0K
Common Stock Issued $0 $0 $0 $0 $71K $0 $6.18M $3.34M
Financing Cash Flow $261.4M $9.96M $130K $174K $250K -$51K $13.34M $3.22M
Net Change in Cash $254.0M $6.49M -$2.96M -- -$2.29M -$1.71M $11.93M $1.75M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 0.0% 5.0% -- 24.6% 34.7% 17.8% 11.0% -- -- --
Operating Margin -27450.0% -5295.6% -- -9714.2% -2139.6% -3059.7% -4853.4% -2172.2% -- --
Net Profit Margin -27235.7% -5271.3% -- -9754.5% -2134.3% -3072.9% -4574.2% -2060.8% -- --
Return on Equity (ROE) -87.3% -118.1% -85.6% -111.2% -54.0% -149.3% -78.4% -101.9% -- --
Return on Assets (ROA) -71.5% -101.6% -75.6% -99.6% -46.9% -115.4% -64.6% -77.2% -84.3% --
Current Ratio 6.94x 7.63x 10.32x 9.58x 8.01x 4.95x 3.41x 3.94x 6.15x --
Quick Ratio 3.23x 7.47x 10.10x 9.36x 7.93x 4.81x 3.37x 2.60x 5.81x --
Debt to Equity 0.04x 0.03x 0.04x 0.01x 0.01x 0.06x 0.02x -- -- --
Revenue Growth (YoY) -76.8% -- -100.0% -76.5% +56.4% +54.7% -52.8% -- -- --
Gross Profit Growth (YoY) -100.0% -- -100.0% -83.3% +204.6% +150.0% -- -- -- --
EPS Growth (YoY) 0.0% -19.4% -31.1% -4.3% -29.9% -24.7% -31.5% -47.8% +822.2% --
5Y Revenue / Share Growth -95.4% -75.3% -100.0% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- 0.0% 0.0% 0.0% 4.0% 5.0%
Operating Margin -- -- -- -27450.0% -8729.0% -6378.9% -4522.9% -5295.6%
Net Profit Margin -- -- -- -27235.7% -8694.4% -6386.7% -4525.1% -5271.3%
Return on Equity (ROE) -10.7% -234.4% -115.8% -87.3% -70.8% -61.4% -52.1% -118.1%
Return on Assets (ROA) -10.6% -87.4% -94.3% -71.5% -61.9% -53.9% -46.7% -101.6%
Current Ratio 128.41x 8.98x 7.93x 6.94x 10.83x 10.47x 13.07x 7.63x
Quick Ratio 123.49x 5.38x 2.62x 3.23x 5.46x 5.89x 7.82x 7.47x
Debt to Equity 0.00x 0.06x 0.04x 0.04x 0.01x 0.01x 0.01x 0.03x
Revenue Growth (YoY) -- -- -100.0% -100.0% -100.0% -100.0% -- --
Gross Profit Growth (YoY) -- -- -- -- -- -100.0% -- --
EPS Growth (YoY) +57.1% +133.3% +16.7% -- -12.5% 0.0% +20.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001638097) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:35 UTC · Open in terminal